The growing demand of efficacious drugs and other major driving factors is expected to favour the rise in the global pharmaceutical solubility and bioavailability enhancement market
Reports and Insights has published a new report titled, “Pharmaceutical Solubility and Bioavailability Enhancement Market: Opportunity Analysis and Future Assessment 2020-2028”
Global Pharmaceutical Solubility and Bioavailability Enhancement Market, By Molecule Type (Small Molecules, Biologics), By Oral Dosage Form (Oral Solid Dosage Form, Oral Liquid Dosage Form), By Technology (Particle size reduction, Lipid Solubilization Modification of Crystal Habit, Solid Dispersions, Complexation, Cryogenic Techniques, Micellar Solubilization Technology), By Excipients Type (Surfactants, Polyethylene Glycols (PEG), Polysorbates, Poloxamers, Solutol HS 15, Polyoxyl stearates, N-methyl-2-pyrrolidone, Ethanol, Glycerin, Lecithin, Docusate sodium (DSS), Sodium lauryl sulfate (SLS), Polymers, Copovidone, HPMC, Polymethacrylates (PMAs), HPMCAS, Povidone (PVP), HPC, Polyvinyl, Caprolactam-polyvinyl acetate-polyethylene glycol copolymer, PEO, HPMCP, Lipid-based excipients, Cyclodextrins, Mesoporous Silica, Dendrimers) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2020 and 2028.
The global pharmaceutical solubility and bioavailability enhancement market in 2020 is estimated for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of xx%.
It goes without saying that a substance will only come into effect if it can be absorbed by the body and thus, bioavailability and solubility has turned to be the couple of the most significant terminologies in case of pharmaceuticals.
Bioavailability (F) can be understood as the rate and magnitude to which the active element or active mediety of a drug is absorbed from a drug product and attains the circulation. In parallel, drug solubility can be perceived as the maximal density of a substance that can be entirely dissolved in a provided solvent at a specific pressure level and temperature. Thus, there is rapid growth in the number of key players engaged in the pharmaceutical solubility and bioavailability enhancement market, which is primarily thrusting the market growth in the forthcoming years.
In addition to that, the growing prevalence of chronic disorders among the population, worldwide, is majorly boosting the demand of efficacious drugs across the global markets, further leading to the swift growth of pharmaceutical solubility and bioavailability enhancement market over the years.
However, there are yet some of the bioavailability issues in proper ADME function of a drug resulting in adverse effects, which may hold back the market growth in the following years. Nevertheless, the rise in development of drugs with high lipophilicity, in the present times, is further projected to offer lucrative opportunities to the market growth in the coming years.
Reports and Insights Study identifies some of the key participating players in the pharmaceutical solubility and bioavailability enhancement market globally are BASF SE, Evonik Industries AG, Lonza Group AG, Ajinomoto Althea Inc., Curia Global, Inc., Catalent, Inc., Ashland Global Specialty Chemicals Inc., DuPont de Nemours, Inc., Merck KGaA, among others.
About Reports and Insights
Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Reports and Insights
For Sales Query: [email protected]
For New Topics & Other Info: [email protected]
Showing 1 reaction
Sign in with